Drug Pricing, Labelling and White Paper

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Drug Pricing

Labelling

White Paper

Inflation, drug pricing and reimbursement constraints will challenge pharma sector

Pharmaceutical Technology

JANUARY 5, 2023

The survey results also indicated that drug pricing and reimbursement constraints will be the second biggest concern, hampering the industry’s growth, as indicated by 30% of the surveyed respondents. To adapt is the only way to thrive. Please check your email to download the Report.

Drug Pricing

Drug Pricing Vaccines Labelling Communication

Exforge antitrust settlement caps Novartis’ year of legal disputes

Pharmaceutical Technology

JANUARY 6, 2023

The alleged actions violated the Hatch-Waxman Act, formally known as the “Drug Price Competition and Patent Term Restoration Act of 1984,” which allows generic manufacturers to market their generic versions of previously approved generic medications. These actions allegedly led to the extension of Novartis’ patents.

Documentation

Documentation Hospitals Dosage Drug Pricing

Pharmacist Digest

Inflation, drug pricing and reimbursement constraints will challenge pharma sector

Exforge antitrust settlement caps Novartis’ year of legal disputes

Stay Connected